In patients with multiple myeloma and chronic lymphocytic leukemia, Talin1 can also promote the abnormal transport of malignant B cells to the bone marrow and lymph nodes by regulating α4β1 integrin activity. This evidence concerns the gene TLN1 and B-cell chronic lymphocytic leukemia.